Adaptive Biotechnologies Balance Sheet Health
Financial Health criteria checks 5/6
Adaptive Biotechnologies has a total shareholder equity of $274.8M and total debt of $131.5M, which brings its debt-to-equity ratio to 47.9%. Its total assets and total liabilities are $620.3M and $345.6M respectively.
Key information
47.9%
Debt to equity ratio
US$131.55m
Debt
Interest coverage ratio | n/a |
Cash | US$308.87m |
Equity | US$274.77m |
Total liabilities | US$345.56m |
Total assets | US$620.32m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1HM's short term assets ($374.0M) exceed its short term liabilities ($83.0M).
Long Term Liabilities: 1HM's short term assets ($374.0M) exceed its long term liabilities ($262.6M).
Debt to Equity History and Analysis
Debt Level: 1HM has more cash than its total debt.
Reducing Debt: 1HM's debt to equity ratio has increased from 0% to 47.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1HM has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1HM has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 36.5% each year